Table 2 Comparison of Outcome Measures Between Moxibustion and Control
From: Moxibustion for cephalic version: a feasibility randomised controlled trial
| Â | Moxibustion (as referent) | Control | Relative Risk (95% CI) | P value |
|---|---|---|---|---|
| Â | N = 10 | N = 10 | Â | Â |
Cephalic presentation (at delivery or before ECV) | 2 (20.0) | 0 (0) | 5.0 (0.27-92.62 | 0.28 |
Cephalic presentation at delivery (including successful ECV) | 5 (50.0) | 1 (10.0) | 5.0 (0.70-35.5) | 0.11 |
ECV | Â | Â | Â | Â |
   Attempted | 4 (40.0) | 6 (60.0) | 0.67 (0.27-1.66) | 0.38 |
   Successful* | 2 (20.0) | 0 (0.0) | 5.0 (0.27-95.62) | 0.28 |
Mode of delivery | Â | Â | Â | Â |
   Vaginal | 4 (40.0) | 1 (10.0) | 4.0 (0.54-29.8) | 0.18 |
   Caesarean | 6 (60.0) | 9 (90.0) | 0.67 (0.39-1.15) | 0.15 |
Other outcomes | Â | Â | Â | Â |
   Preterm birth requiring hospitalisation | 2 (20.0) | 0 (0) | 5.0 (0.27-92.62) | 0.28 |
   Prelabour rupture of membranes at < 37 weeks | 3 (30.0) | 0 (0) | 7.0 (0.41, 120.16) | 0.18 |
Gestational age at delivery | 38.7 (2.11) | 39.9 (3.68) | Â | 0.43 |
Apgar score < 7 at 5 min | 0 (0) | 0 (0) | N/A | Â |
Birthweight (g) | 3224 (653.9) | 3193 (674) | Â | 0.92 |
Admission to NICU | 2 (20.0) | 0 (0) | N/A | Â |